Predicting ovarian function loss after chemotherapy and anti-HER2 therapy in young breast cancer patients. Lambertini M, Allegranza D, Laubender RP, Harbeck N, et al. J Natl Cancer Inst 2025 Aug 12:djaf198. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Lambertini M, Allegranza D, Laubender RP, Harbeck N, et al. Predicting ovarian function loss after chemotherapy and anti-HER2 therapy in young breast cancer patients. J Natl Cancer Inst 2025 Aug 12:djaf198. doi: 10.1093.
PMID: 40796347